Role of peroxynitrite in methamphetamine-induced dopaminergic neurotoxicity and sensitization in mice

Addiction Biology

Volumn 5, Issue 3, 2000, Pages 331-341

  Ali, Syed F ^a   Haung, Paul ^b   Itzhak, Yossef ^c  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 NITROINDAZOLE; DOPAMINE; DOPAMINE TRANSPORTER; METHAMPHETAMINE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; PSYCHOSTIMULANT AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; BINDING SITE; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; LOCOMOTION; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION;

EID: 0033910348     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2000.tb00200.x     Document Type: Conference Paper

References (62)

1. 1. Sieden LS, Fischman MW, Schuster CR. Long-term methamphetamine-induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend 1975;1:215-19.
2. 2. Ellison G, Eison MS, Huberman HS, Daniel F. Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration. Science 1978;201:1-10.
3. 3. Wagner GC, Ricaurte GA, Seiden LS, Schuster CR, Miller RJ, Westley J. Long-lasting depletion of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 1980;181:151-60.
4. 4. Itzhak Y, Gandia C, Huang PL, Ali SF. Resistance to neuronal nitric oxide synthase deficient mice to methamphetamine-induced dopaminergic neurotoxicity in vivo. J Pharmacol Exp Ther 1998;284:1040-47.
5. 5. Hotchkis AJ, Gibb JW. The long-term effetcs of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities. J Pharmacol Exp Ther 1979;214: 257-62.
6. 6. Wilson JM, Kalasinsky KS, Levey AI et al. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nature Med 1996;2:699-703.
7. 7. Cadet JL, Brannock C. Free radicals and pathobiology of brain dopamine system. Neurochem Int 1998;32:117-31.
8. 8. Cubells JF, Rayport S, Rayndrion G, Sulzer D. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J Neurosci 1994; 14:2260-71.
9. 9. Cadet JL, Sheng P, Ali SF, Rothman RB, Carlson E, Epstein C. Attenuation of methamphetamine-7 induced neurotoxicity in copper/zinc superoxide dismutase in transgenic mice. J Neurochem 1994;62:380-3.
10. 10. Cadet JL, Ali SF, Rothman RB, Epstein C. Neurotoxicity, drugs of abuse and CuZn-superoxide dismutase transgenic mice. Mol Neurobiol 1995;11:145-55.
11. 11. Giovanni A, Liang LP, Hastings TG, Zigmond M.J. Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J Neurochem 1995;64:1819-25.
12. 12. Gibb JW, Johnson M, Hanson GR. Neurochemical basis of neurotoxicity. Neurotoxicology 1990;11: 317-21.
13. 13. De Vito MJ, Wagner GC. Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacology 1989;28:1145-50.
14. 14. Itzhak Y, Martin JL, Black DM, Ali SF. Effects of melatonin on methamphetamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization. Neuropharmacology 1998;37:781-91.
15. 15. Imam SZ, Crow JP, Newport GD, Islam F, Slikker W Jr, Ali SF. Methamphetamine generate peroxynitrite and produces dopaminergic neurotoxicity in mice: protective effects of peroxynitrite decomposition catalyst. Brain Res 1999;837:15-21.
16. 16. Imam SZ, Newport GD, Islam F, Slikker W Jr, Ali SF Selenium, an antioxidant, protects against methamphetamine-induced dopaminergic neurotoxicity. Brain Res 1999;818:575-8.
17. 17. Hom DG, Jiang D, Hong E, Mo JQ, Anderson JK. Elevated expression of glutathione peroxidase in PC12 cells results in protection against methamphetamine but not MPTP toxicity. Mol. Brain Res 1997;46:154-60.
18. 18. Subramaniam SJ, Landenheim B, Cadet JL. Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide transgenic mice, Ann NY Acad Sci 1998;844:92-102.
19. 19. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of Superoxide and nitric oxide. J Biol Chem 1991;266:4244-50.
20. 20. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991b;288: 481-7.
21. 21. Rubbo H, Radi R, Trujillo M et al. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation: formation of novel nitrogen-containing lipid derivatives. J Biol Chem 1994;269:26066-75.
22. 22. Salvemini D, Wang Z, Stern MK, Currie MG, Misko TP. Peroxynitrite decomposition catalysts: therapeutics for peroxynitrite-mediated pathology. Proc Natl Acad Sci USA 1998;95:2659-63.
23. 23. Van der Vliet A, O'Neill CA, Halliwell B, Cross CE, Kaur H. Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitrite: evidence for hydroxyl radical production from peroxynitrite. FEBS Lett 1994;339:89-92.
24. 24. Van der Vliet A, Eiserich JP, O'Neill CA., Halliwell B, Cross CE. Tyrosine modification by reactive nitrogen species: a closer look. Arch Biochem Biophys 1995;319:341-9.
25. 25. Beckman J, Chen S, Ischiropoulos H, Crow JP.Oxidative chemistry of peroxynitrite. Methods Enzymol 1994;223:229-40.
26. 26. Ischiropoulos H, Zhu L, Beckman JS. Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys 1992;298:446-51.
27. 27. Beckman JS, Beckman TW, Chen J, Marshall PM, Freeman BA. Apparent hydroxy radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1621-4.
28. 28. Zhang J, Dawson VL, Dawson TM, Snyder SH. Nitric oxide activation of poly(ADP-Ribose) synthetase in neurotoxicity. Science 1994;263:687-9.
29. 29. Garthwaite J. Glutamate, nitric oxide, and cell-cell signaling in the nervous system. Trends Neurosci 1991;14:60-7.
30. 30. Snyder SH. Nitric oxide: first in a new class of neurotransmitters? Science 1992;257:494-6.
31. 31. Itzhak Y. Attenuation of cocaine kindling by 7-nitroindazole, an inhibitor of brain nitric oxide synthase. Neuropharmacology 1996;35:1065-73.
32. 32. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC. Targeted disruption of neuronal nitric oxide synthase gene. Cell 1993;75: 1273-86.
33. 33. Itzhak Y, Martin JL, Ali SF. Methamphetamine-and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice. Synapse 1999;34; 305-12.
34. 34. Itzhak Y. Modulation of cocaine-and methamphetamine-induced behavioral sensitization by inhibition of brain nitric oxide synthase. J Pharmacol Exp Ther 1997;282:521-7.
35. 35. Ali SF, Newport GD, Holson RR, Slikker W Jr, Bowyer JF. Low environmental temperature or pharmacologic agents which produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res 1994;658:33-8.
36. 36. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurements with Folin phenol reagent. J Biol Chem 1951;193:265-75.
37. 37. Ali SF, Itzhak Y. Effects of 7-nitroindazole, an NOS inhibitor on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in mice Ann NY Acad Sci 1998;844:122-30.
38. 38. Itzhak Y, Ali SF. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J Neurochem 1996;67:1770-3.
39. 39. AbekawaT, Ohmori T, Koyama T. Effect of nitric oxide synthesis inhibition on methamphetamine-induced dopaminergic and serotoninergic neurotoxicity in the rat brain. J Neural Transm 1996;103:671-80.
40. 40. Strasser A, McCarron RM, Ishii H, Stanimirovic D, Spatz M. L-Arginine induces dopamine release from the striatum in vivo. NeuroReport 1994;5:2298-300.
41. 41. Sheng P, Cerruit C, Ali SF, Cadet JL. Nitric oxide is a mediator of methamphetamine-induced neurotoxicity: in vitro evidence from primary cultures of mesencephalic cells. Ann NY Acad Sci 1996;801:174-86.
42. 42. Schulz JB, Matthews RT, Muqit MMK, Browne SE, Beal MF. Inhibition of neuronal nitric oxide synthase protects against MPTP-induced neurotoxicity in mice. J Neurochem 1995;64: 936-9.
43. 43. Hantraye P, Brouillet E, Ferrante R et al. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nature Med 1996;2:1017-102.
44. 44. Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson VL, Dawson TM. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Nad Acad Sci USA 1996;93:4565-71.
45. 45. Schulz BJ, Huang PL, Matthews RT, Passov D, Fishman MC, Beal MF. Striatal malonate lesions are attenuated in neuronal nitric oxide synthase knockout mice. J Neurochem 1996;67:430-3.
46. 46. Bowyer JF, Tank AW, Newport GD, Slikker W Jr, Ali SF, Holson RR. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J Pharmacol Exp Ther 1992;260: 817-24.
47. 47. Miller DB, O'Callagahan JP. Environmental-, drug-and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 1994;270:752-76.
48. 48. Kuperman DI, Freyladenhoven TF, Schmued L, Ali SF. Methamphetamine-induced hyperthermia in mice: examination of dopamine depletion and heat shock protein induction. Brain Res 1997;771: 221-7.
49. 49. Yu X, Imam SZ, Newport GD, Slikker W Jr, Ali SF. Role of ibogaine in methamphetamine-induced hyperthermia and dopaminergic neurotoxicity. Brain Res 1999;823:213-16.
50. 50. Ali SF, Newport GD, Slikker W Jr. Methamphetamine-induced dopaminergic toxicity in mice: role of environmental temperature and pharmacological agents. Ann NY Acad Sci 1996;801:187-98.
51. 51. Robinson TE, Becker JB. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 1986;396:157-98.
52. 52. Segal DS, Kuczenski R. An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics. J Neurosci 1997;17: 2551-66.
53. 53. Robinson TE, Berridge C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 1993;18:247-91.
54. 54. Robinson TE, Yew J, Paulson PE, Camp DM. The long-term effects of neurotoxic doses of methamphetamine on the extracellular concentration of dopamine measured with microdialysis in striatum. Neurosci Lett 1990;110:193-8.
55. 55. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996;379:06-12.
56. 56. Nash JF, Yamamoto BK. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Res 1992;581:237-43.
57. 57. Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH. Mechanisms of nitric-oxide mediated neurotoxicity in primary brain cultures. J Neurochem 1993;13:2651-61.
58. 58. Xue C-J, Ng JP, Li Y, Wolf ME. Acute and repeated amphetamine administration: effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens. J Neurochem 1996;67:352-63.
59. 59. Carlsson M, Carlsson A. Interaction between glutamatergic and monoaminergic systems within the basal ganglia: implications for schizophrenia and Parkinson's disease. Trends Neurosci 1990;13: 272-6.
60. 60. Lonart G, Cassels KL, Johnson KM. Nitric oxide induces calcium-dependent [3H] dopamine release from striatal slices. J Neurosci Res 1993;35: 192-8.
61. 61. Montague PR, Gancayco CD, Winn MJ, Marchase RB, Fridlander MJ. Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science 1994;263: 973-7.
62. 62. Imam SZ, Ali SF. Selenium, an antioxidant, attenuates methamphetamine-induced peroxynitrite generation in mice. Ann NY Acad Sci 2000;855:191-200.